Oncology

FIGO Global Declaration on Cervical Cancer Elimination

FIGO membership aligns with WHO and the UNFPA to eliminate Cervical Cancer.

New hereditary cancer risk tool launched by UK charity

A new tool has been developed by a UK charity to help people identify if their family history puts them at greater risk of developing ovarian and other cancers. Ovarian Cancer Action has created the Hereditary Cancer Risk Tool, which lays out a series of questions regarding a person's family...

The voice for women's health

Making FIGO’s voice, and that of our member societies, much louder and more relevant at this years World Health Assembly, Geneva...

Addressing Gynecological Oncology at WHA71

FIGO delivered an Official Side Event on Gynecological Oncology – Early Detection and Prevention at the 71 st World Health Assembly...

Six months of breast cancer treatment ‘could be as effective as 12 in some women’

Six months of targeted drug therapy could potentially be as effective as treatment lasting 12 months for women with a type of early stage breast cancer. This is according to unpublished clinical trial results. Roughly nine in ten women taking trastuzumab - sold under the brand name Herceptin - for...

HPV vaccine found to be ‘safe and effective’

The human papillomavirus (HPV) vaccine offered to teenage girls in the UK is safe and effective in its protection against a virus that can cause cervical cancer. This is according to a new independent review by the Cochrane Group. It looked at 26 trials covering 73,428 girls or women and found that...

Global ovarian cancer rates 'set to rise significantly'

The number of women being diagnosed with ovarian cancer is likely to see a significant increase over the next two decades, according to a new study. The World Ovarian Cancer Coalition, a group of patient organisations, has published its 2018 Every Woman Study, which has collated data from 1,000...

Pill may be better than mammograms at diagnosing breast cancer

Researchers from the University of Michigan in the US have developed a new method of diagnosing breast cancer that may be significantly more effective than mammograms. The team at the university has been working on a pill that will make tumours light up when exposed to infrared light, with this...

Breast cancer drug shown to accelerate tumour growth in lab tests

A certain type of breast cancer drug may actually be causing cancer cell growth to accelerate under some circumstances, according to new research. Scientists from the UK's Francis Crick Institute, King's College London and Barts Cancer Institute at the Queen Mary University of London have...

Gene tests help identify best treatment for one kind of breast cancer

New research has found that aggressive breast cancers where a particular faulty gene is present will respond more readily to a particular type of treatment, Cancer Research UK has revealed. A study jointly funded by Cancer Research UK and Breast Cancer Now found that where a faulty BRCA gene is...